ChromaDex Corp. - FORM 10-Q - EX-10.4 - TAKE OR PAY PURCHASE AGREEMENT FOR NICOTINAMIDE RIBOSIDE CHLORIDE, EFFECTIVE AS OF SEPTEMBER 21, 2015, BETWEEN W.R. GRACE & CO. CONN. AND CHROMADEX, INC. - November 12, 2015

Attached files

file filename
EX-10.1 - EXCLUSIVE SUPPLY AGREEMENT, EFFECTIVE AS OF AUGUST 27, 2015 BETWEEN HEALTHSPAN RESEARCH, LLC. AND CHROMADEX, INC. - ChromaDex Corp.ex10-1.htm
EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 (AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES?OXLEY ACT OF 2002) - ChromaDex Corp.ex32-1.htm
EX-31.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO ?240.13A?14 OR ?240.15D?14 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED - ChromaDex Corp.ex31-2.htm
EX-10.3 - INTEREST PURCHASE AGREEMENT, EFFECTIVE AS OF AUGUST 27, 2015 BETWEEN HEALTHSPAN RESEARCH LLC AND CHROMADEX, INC. - ChromaDex Corp.ex10-3.htm
EX-10.5 - SUPPLY AGREEMENT, EFFECTIVE AS OF AUGUST 28, 2015 AND FIRST ADDENDUM TO SUPPLY AGREEMENT, EFFECTIVE AS OF SEPTEMBER 30, 2015 BETWEEN NECTAR7 LLC AND CHROMADEX, INC. - ChromaDex Corp.ex10-5.htm
EX-10.2 - LIMITED LIABILITY COMPANY AGREEMENT, EFFECTIVE AS OF AUGUST 27, 2015 BETWEEN HEALTHSPAN RESEARCH LLC AND CHROMADEX, INC. - ChromaDex Corp.ex10-2.htm
10-Q - FORM 10-Q - ChromaDex Corp.cdxc10q_oct032015.htm
EX-31.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO ?240.13A?14 OR ?240.15D?14 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED - ChromaDex Corp.ex31-1.htm
Exhibit 10.4
 
[*] INDICATES CONFIDENTIAL PORTION HAS BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION

 
 
  T +1 410.531.4000
 
W. R. Grace & Co.-Conn.
7500 Grace Drive
Columbia, MD 21044
 
September 21, 2015

Troy Rhonemus
Chief Operating Officer
ChromaDex, Inc.
10005 Muirlands Blvd.
Suite G
Irvine CA, 92618

Re:           Take or Pay Purchase Agreement for nicotinamide riboside chloride

Dear Mr. Rhonemus:

ChromaDex, Inc. (“ChromaDex”) currently purchases nicotinamide riboside chloride (the “Product”) from W. R. Grace & Co.-Conn. (“Grace”) under terms agreed to by both ChromaDex and Grace. Notwithstanding any such terms, ChromaDex and Grace agree that the following purchase obligation and related terms shall apply, effective as of the date of this letter agreement:

ChromaDex shall purchase from Grace not less than [*] kg of Product (the “Required Amount”) between September 4, 2015 and December 31, 2015 at a price of $[*] per kg. In the event that ChromaDex does not purchase the full Required Amount by December 31, 2015, ChromaDex shall pay to Grace $[*] per kg for the difference, in kilograms, between the amount actually purchased by ChromaDex and the Required Amount.

Any payment by ChromaDex for a shortfall between the Required Amount and the amount of Product actually purchased is due by February 14, 2016.

Grace will ship the purchased Products to ChromaDex on a schedule to be agreed to by the parties.   Payment will be net 60 for any quantities of the Required Volume that ship after December 31, 2015.

 
 
 
[*] INDICATES CONFIDENTIAL PORTION HAS BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION
 
 
 
All other terms and conditions currently governing the purchase of the Product remain in full force and effect. In the event of any conflict or inconsistencies between the provisions in this letter agreement and those as currently agreed to by ChromaDex and Grace, the provisions in this letter agreement shall control.

This letter agreement may be executed in one or more counterparts, each of which will be deemed to be an original of this letter agreement and all of which, when taken together, will be deemed to constitute one and the same letter agreement.

If you are in agreement with the foregoing, please have letter agreement signed by an authorized representative and return one fully executed original to:

Kathrine Kastberg
W. R. Grace & Co.-Conn.
7500 Grace Drive
Columbia, MD 21044

If there are any questions, please contact Audrey Kelleman at (858) 342-5367.

       
CHROMADEX, INC.
  
W. R. GRACE & CO.-CONN.
  
       
By:
 
/s/ Troy Rhonemus
  
By:
 
/s/ Brett Reynolds
  
           
Name:
Troy Rhonemus
  
Name:
Brett Reynolds
  
           
Title:
COO
  
Title:
Business Director, Fine Chemicals
  
           
Date:
9/29/2015
  
Date:
9/22/2015
  

 

ChromaDex Corp. Reports

Also read